Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

Dow Jones outperforms other US stock indices in the face of Donald Trump's election The index, with its strong industrial ...

Merck posted sales of 5.17 billion euros in the prior-year ... the team adds. RHB raises the stock’s target price to S$1.07 from S$1.02 with an unchanged buy rating. Shares are 1.7% higher at S$0.915.

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

(Reuters) -Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, ...

The German life-science and chemicals company attributed earnings growth to a recovery of its life-science segment, cost discipline and lower spending on research and development following the ...

Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...

Germany's Merck KGaA expects annual sales to be at the lower half of its outlook range after third-quarter sales missed expectations. The life-sciences and chemical group said Thursday that it now ...

Liberty Media Corp. Series C Liberty Formula One 5.72% $24.92B Liberty Media Corp. Series A Liberty Formula One 4.60% $24.92B Liberty Broadband Corp. Cl A-4.67% $13.93B Liberty Broadband Corp. Cl ...